{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T21:41:12Z","timestamp":1774906872576,"version":"3.50.1"},"reference-count":83,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1016\/j.beem.2010.11.001","type":"journal-article","created":{"date-parts":[[2011,6,19]],"date-time":"2011-06-19T16:27:38Z","timestamp":1308500858000},"page":"517-529","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Growth hormone and HIV infection: Contribution to disease manifestations and clinical implications"],"prefix":"10.1016","volume":"25","author":[{"given":"Julian","family":"Falutz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.beem.2010.11.001_bib1","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0140-6736(08)61113-7","article-title":"Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies","volume":"372","author":"Hogg","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.beem.2010.11.001_bib2","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1097\/QAD.0b013e3283365356","article-title":"Risk of all-cause mortality associated with nonfatal AIDS and serious non-AIDS events among adults infected with HIV","volume":"24","author":"Neuhaus","year":"2010","journal-title":"AIDS"},{"key":"10.1016\/j.beem.2010.11.001_bib3","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1097\/QAD.0b013e32832e9b78","article-title":"Non-AIDS-defining deaths and immunodeficiency in the era of combination antiretroviral therapy","volume":"23","author":"Marin","year":"2009","journal-title":"AIDS"},{"key":"10.1016\/j.beem.2010.11.001_bib4","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/ncpendmet0587","article-title":"Therapy insight: body-shape changes and metabolic complications associated with HIV and highly active antiretroviral therapy","volume":"3","author":"Falutz","year":"2007","journal-title":"Nature Clinical Practice Endocrinology Metabolism"},{"key":"10.1016\/j.beem.2010.11.001_bib5","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1089\/apc.2005.19.577","article-title":"Lipodystrophy-associated symptoms and medication adherence in HIV\/AIDS","volume":"19","author":"Corless","year":"2005","journal-title":"AIDS Patient Care and STDs"},{"key":"10.1016\/j.beem.2010.11.001_bib6","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1136\/hrt.2008.161463","article-title":"Cardiovascular manifestations of HIV infection","volume":"95","author":"Ho","year":"2009","journal-title":"Heart"},{"key":"10.1016\/j.beem.2010.11.001_bib7","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1086\/367561","article-title":"Weight loss and wasting in patients infected with human immunodeficiency virus","volume":"36","author":"Grinspoon","year":"2003","journal-title":"Clinical Infectious Disease"},{"key":"10.1016\/j.beem.2010.11.001_bib8","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s11102-008-0092-8","article-title":"GH\/GHRH axis in HIV lipodystrophy","volume":"12","author":"Stanley","year":"2009","journal-title":"Pituitary"},{"key":"10.1016\/j.beem.2010.11.001_bib9","first-page":"518","article-title":"Endocrine and metabolic disturbances in human immunodeficiency virus infection and the acquired immune deficiency syndrome","volume":"17","author":"Sellmeyer","year":"1996","journal-title":"Endocrine Reviews"},{"key":"10.1016\/j.beem.2010.11.001_bib10","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1177\/135965350701200215","article-title":"Hypogonadism in HIV-1-infected men is common and does not resolve during antiretroviral therapy","volume":"12","author":"Wunder","year":"2007","journal-title":"Antiviral Therapy"},{"key":"10.1016\/j.beem.2010.11.001_bib11","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.cell.2007.05.047","article-title":"Endocrine regulation of energy metabolism by the skeleton","volume":"130","author":"Lee","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.beem.2010.11.001_bib12","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1210\/jcem.87.5.8474","article-title":"Familial isolated growth hormone deficiency is associated with increased systolic blood pressure, central obesity, and dyslipidemia","volume":"87","author":"Barreto-Filho","year":"2002","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2010.11.001_bib13","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1086\/500398","article-title":"Nutrition and HIV infection: review of weight loss and wasting in the era of highly active antiretroviral therapy from the nutrition for healthy living cohort","volume":"42","author":"Mangili","year":"2006","journal-title":"Clinical Infectious Disease"},{"key":"10.1016\/j.beem.2010.11.001_bib14","first-page":"4028","article-title":"Circadian growth hormone secretion in asymptomatic human immune deficiency virus infection and acquired immunodeficiency syndrome","volume":"81","author":"Heijligenberg","year":"1996","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2010.11.001_bib15","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/S0026-0495(96)90140-7","article-title":"Anterior pituitary and pituitary-dependent target organ function in men infected with the human immunodeficiency virus","volume":"45","author":"Wilson","year":"1996","journal-title":"Metabolism"},{"key":"10.1016\/j.beem.2010.11.001_bib16","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1046\/j.1365-2265.1996.705526.x","article-title":"Wasting in the acquired immune deficiency syndrome is associated with multiple defects in the serum insulin-like growth factor system","volume":"44","author":"Frost","year":"1996","journal-title":"Clinical Endocrinology"},{"key":"10.1016\/j.beem.2010.11.001_bib17","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.cccn.2005.05.001","article-title":"Monitoring insulin-like growth factors in HIV infection and AIDS","volume":"361","author":"Congote","year":"2005","journal-title":"Clinica Chimica Acta"},{"key":"10.1016\/j.beem.2010.11.001_bib18","first-page":"4251","article-title":"Effects of androgen administration on the growth hormone-insulin-like growth factor I axis in men with acquired immunodeficiency syndrome wasting","volume":"83","author":"Grinspoon","year":"1998","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2010.11.001_bib19","doi-asserted-by":"crossref","first-page":"324","DOI":"10.3181\/00379727-212-44021A","article-title":"Catabolic hormones and growth hormone resistance in acquired immunodeficiency syndrome and other catabolic states","volume":"212","author":"Rodgers","year":"1996","journal-title":"Proceedings of the Society for Experimental Biology and Medicine"},{"key":"10.1016\/j.beem.2010.11.001_bib20","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0272-6386(99)70223-4","article-title":"Double-blind, placebo-controlled study of growth hormone treatment in elderly patients undergoing chronic hemodialysis: anabolic effect and functional improvement","volume":"33","author":"Johannsson","year":"1999","journal-title":"American Journal of Kidney Disease"},{"key":"10.1016\/j.beem.2010.11.001_bib21","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/00000658-199902000-00020","article-title":"Perioperative growth hormone treatment and functional outcome after major abdominal surgery: a randomized, double-blind, controlled study","volume":"229","author":"Kissmeyer-Nielsen","year":"1999","journal-title":"Annals of Surgery"},{"key":"10.1016\/j.beem.2010.11.001_bib22","first-page":"245","article-title":"Anthropometric, metabolic, and immunological effects of recombinant human growth hormone in AIDS and AIDS-related complex","volume":"6","author":"Krentz","year":"1993","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"key":"10.1016\/j.beem.2010.11.001_bib23","first-page":"E1071","article-title":"Growth hormone-induced insulin resistance: role of the insulin receptor, IRS-1, GLUT-1, and GLUT-4","volume":"272","author":"Smith","year":"1997","journal-title":"The American Journal of Physiology"},{"key":"10.1016\/j.beem.2010.11.001_bib24","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1210\/jc.2003-030218","article-title":"Growth hormone replacement therapy and insulin sensitivity","volume":"88","author":"Svensson","year":"2003","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2010.11.001_bib25","doi-asserted-by":"crossref","first-page":"873","DOI":"10.7326\/0003-4819-125-11-199612010-00002","article-title":"Recombinant human growth hormone in patients with HIV-associated wasting. A randomized, placebo-controlled trial. Serostim study group","volume":"125","author":"Schambelan","year":"1996","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.beem.2010.11.001_bib26","first-page":"404","article-title":"Anabolic effects of recombinant insulin-like growth factor-I in cachectic patients with the acquired immunodeficiency syndrome","volume":"78","author":"Lieberman","year":"1994","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2010.11.001_bib27","first-page":"2968","article-title":"A randomized, placebo-controlled trial of combined insulin-like growth factor I and low dose growth hormone therapy for wasting associated with human immunodeficiency virus infection","volume":"81","author":"Lee","year":"1996","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2010.11.001_bib28","doi-asserted-by":"crossref","first-page":"865","DOI":"10.7326\/0003-4819-125-11-199612010-00001","article-title":"Recombinant human growth hormone, insulin-like growth factor 1, and combination therapy in AIDS-associated wasting. A randomized, double-blind, placebo-controlled trial","volume":"125","author":"Waters","year":"1996","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.beem.2010.11.001_bib29","first-page":"3033","article-title":"Changes in body composition of human immunodeficiency virus-infected males receiving insulin-like growth factor I and growth hormone","volume":"81","author":"Ellis","year":"1996","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2010.11.001_bib30","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1097\/00002030-200305020-00005","article-title":"Prospective evaluation of the effects of antiretroviral therapy on body composition in HIV-1-infected men starting therapy","volume":"17","author":"Mallon","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.beem.2010.11.001_bib31","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/01.qai.0000159627.54149.2e","article-title":"Increasing risk of 5% or greater unintentional weight loss in a cohort of HIV-infected patients, 1995 to 2003","volume":"40","author":"Tang","year":"2005","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"key":"10.1016\/j.beem.2010.11.001_bib32","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/00126334-200404010-00006","article-title":"Growth hormone improves lean body mass, physical performance, and quality of life in subjects with HIV-associated weight loss or wasting on highly active antiretroviral therapy","volume":"35","author":"Moyle","year":"2004","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"issue":"7","key":"10.1016\/j.beem.2010.11.001_bib33","doi-asserted-by":"crossref","first-page":"F51","DOI":"10.1097\/00002030-199807000-00003","article-title":"A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors","volume":"12","author":"Carr","year":"1998","journal-title":"AIDS"},{"key":"10.1016\/j.beem.2010.11.001_bib34","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1194\/jlr.R300019-JLR200","article-title":"Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host","volume":"45","author":"Khovidhunkit","year":"2004","journal-title":"Journal of Lipid Research"},{"key":"10.1016\/j.beem.2010.11.001_bib35","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1177\/135965350501000511","article-title":"Lipid profiles for antiretroviral-naive patients starting PI- and NNRTI-based therapy in the Swiss HIV cohort study","volume":"10","author":"Young","year":"2005","journal-title":"Antiviral Therapy"},{"key":"10.1016\/j.beem.2010.11.001_bib36","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1097\/01.aids.0000181011.62385.91","article-title":"Cumulative exposure to nucleoside analogue reverse transcriptase inhibitors is associated with insulin resistance markers in the multicenter AIDS cohort study","volume":"19","author":"Brown","year":"2005","journal-title":"AIDS"},{"key":"10.1016\/j.beem.2010.11.001_bib37","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.mito.2004.07.025","article-title":"Mitochondrial dysfunction in AIDS and its treatment","volume":"4","author":"Gerschenson","year":"2004","journal-title":"Mitochondrion"},{"key":"10.1016\/j.beem.2010.11.001_bib38","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1086\/423176","article-title":"Mitochondrial effects of HIV infection on the peripheral blood mononuclear cells of HIV-infected patients who were never treated with antiretrovirals","volume":"39","author":"Miro","year":"2004","journal-title":"Clinical Infectious Disease"},{"key":"10.1016\/j.beem.2010.11.001_bib39","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.molmed.2010.03.002","article-title":"HIV-associated lipodystrophy: from fat injury to premature aging","volume":"16","author":"Caron-Debarle","year":"2010","journal-title":"Trends in Molecular Medicine"},{"key":"10.1016\/j.beem.2010.11.001_bib40","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1097\/QAD.0b013e32830b3a96","article-title":"Genetic polymorphisms differently influencing the emergence of atrophy and fat accumulation in HIV-related lipodystrophy","volume":"22","author":"Zanone Poma","year":"2008","journal-title":"AIDS"},{"key":"10.1016\/j.beem.2010.11.001_bib41","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/01.qai.0000182230.47819.aa","article-title":"Fat distribution in men with HIV infection","volume":"40","author":"Bacchetti","year":"2005","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"key":"10.1016\/j.beem.2010.11.001_bib42","doi-asserted-by":"crossref","first-page":"3845","DOI":"10.1210\/jcem.86.8.7731","article-title":"Abdominal visceral fat and fasting insulin are important predictors of 24-hour GH release independent of age, gender, and other physiological factors","volume":"86","author":"Clasey","year":"2001","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2010.11.001_bib43","first-page":"504","article-title":"Assessment of growth hormone dynamics in human immunodeficiency virus-related lipodystrophy","volume":"86","author":"Rietschel","year":"2001","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2010.11.001_bib44","doi-asserted-by":"crossref","first-page":"E296","DOI":"10.1152\/ajpendo.00335.2003","article-title":"Metabolic regulation of growth hormone by free fatty acids, somatostatin, and ghrelin in HIV-lipodystrophy","volume":"286","author":"Koutkia","year":"2004","journal-title":"American Journal of Physiology Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2010.11.001_bib45","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1210\/jc.2004-1342","article-title":"Growth hormone (GH) responses to GH-releasing hormone-arginine testing in human immunodeficiency virus lipodystrophy","volume":"90","author":"Koutkia","year":"2005","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2010.11.001_bib46","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1080\/00365540410021162","article-title":"Different growth hormone sensitivity of target tissues and growth hormone response to glucose in HIV-infected patients with and without lipodystrophy","volume":"36","author":"Andersen","year":"2004","journal-title":"Scandinavian Journal of Infectious Diseases"},{"key":"10.1016\/j.beem.2010.11.001_bib47","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2165\/00063030-200822020-00003","article-title":"Recombinant human growth hormone: rationale for use in the treatment of HIV-associated lipodystrophy","volume":"22","author":"Benedini","year":"2008","journal-title":"BioDrugs"},{"key":"10.1016\/j.beem.2010.11.001_bib48","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1210\/jc.2004-0894","article-title":"Truncal adiposity, relative growth hormone deficiency, and cardiovascular risk","volume":"90","author":"Miller","year":"2005","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2010.11.001_bib49","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1210\/jc.2004-0545","article-title":"Clinical review: growth hormone and cardiovascular risk factors","volume":"90","author":"Gola","year":"2005","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2010.11.001_bib50","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1210\/jc.2007-2371","article-title":"Growth hormone decreases visceral fat and improves cardiovascular risk markers in women with hypopituitarism: a randomized, placebo-controlled study","volume":"93","author":"Beauregard","year":"2008","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2010.11.001_bib51","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1210\/jc.2008-1357","article-title":"Effects of recombinant human growth hormone therapy in obesity in adults: a meta analysis","volume":"94","author":"Mekala","year":"2009","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2010.11.001_bib52","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1056\/NEJMoa030218","article-title":"Combination antiretroviral therapy and the risk of myocardial infarction","volume":"349","author":"Friis-Moller","year":"2003","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.beem.2010.11.001_bib53","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1086\/655144","article-title":"Low CD4\u00a0+\u00a0T cell count is a risk factor for cardiovascular disease events in the HIV outpatient study","volume":"51","author":"Lichtenstein","year":"2010","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.beem.2010.11.001_bib54","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1089\/aid.2009.0052","article-title":"Treatment with recombinant growth hormone is associated with modest improvement in CD4 lymphocyte reconstitution in HIV-infected persons on antiretroviral therapy: results of ACTG A5174","volume":"26","author":"Smith","year":"2010","journal-title":"AIDS Research and Human Retroviruses"},{"issue":"Suppl. 2","key":"10.1016\/j.beem.2010.11.001_bib55","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1097\/QAI.0b013e318186521a","article-title":"Management of morphologic changes associated with antiretroviral use in HIV-infected patients","volume":"49","author":"Wohl","year":"2008","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"key":"10.1016\/j.beem.2010.11.001_bib56","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/0026-0495(90)90297-P","article-title":"Visceral fat accumulation in men is positively associated with insulin, glucose, and C-peptide levels, but negatively with testosterone levels","volume":"39","author":"Seidell","year":"1990","journal-title":"Metabolism"},{"key":"10.1016\/j.beem.2010.11.001_bib57","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1210\/jc.2006-2060","article-title":"Effects of testosterone supplementation on whole body and regional fat mass and distribution in human immunodeficiency virus-infected men with abdominal obesity","volume":"92","author":"Bhasin","year":"2007","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2010.11.001_bib58","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1001\/jama.284.4.472","article-title":"Metformin in the treatment of HIV lipodystrophy syndrome: a randomized controlled trial","volume":"284","author":"Hadigan","year":"2000","journal-title":"Journal of American Medical Association"},{"key":"10.1016\/j.beem.2010.11.001_bib59","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1210\/jc.2008-1588","article-title":"The effects of recombinant human leptin on visceral fat, dyslipidemia, and insulin resistance in patients with human immunodeficiency virus-associated lipoatrophy and hypoleptinemia","volume":"94","author":"Mulligan","year":"2009","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2010.11.001_bib60","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/oby.2003.3","article-title":"Adipose tissue quantification by imaging methods: a proposed classification","volume":"11","author":"Shen","year":"2003","journal-title":"Obesity Research"},{"key":"10.1016\/j.beem.2010.11.001_bib61","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.2337\/dc07-9921","volume":"30","author":"Klein","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.beem.2010.11.001_bib62","first-page":"305","article-title":"Dual-energy X-ray absorptiometry and body composition","volume":"8","author":"Plank","year":"2005","journal-title":"Current Opinion in Clinical Nutrition and Metabolic Care"},{"key":"10.1016\/j.beem.2010.11.001_bib63","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.nut.2005.01.007","article-title":"Waist circumference criteria for the diagnosis of abdominal obesity are not applicable uniformly to all populations and ethnic groups","volume":"21","author":"Misra","year":"2005","journal-title":"Nutrition"},{"key":"10.1016\/j.beem.2010.11.001_bib64","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1089\/met.2008.0078","article-title":"Is a unified definition of metabolic syndrome needed? Comparison of three definitions of metabolic syndrome in 60-year-old men and women","volume":"7","author":"Carlsson","year":"2009","journal-title":"Metabollic Syndrome and Related Disorders"},{"issue":"Suppl. B","key":"10.1016\/j.beem.2010.11.001_bib65","first-page":"23B","article-title":"Hypertriglyceridemic waist: a useful screening phenotype in preventive cardiology?","volume":"23","author":"Lemieux","year":"2007","journal-title":"The Canadian Journal of Cardiology"},{"key":"10.1016\/j.beem.2010.11.001_bib66","doi-asserted-by":"crossref","first-page":"313","DOI":"10.7326\/0003-4819-131-4-199908170-00024","article-title":"Reversal of protease inhibitor-related visceral abdominal fat accumulation with recombinant human growth hormone","volume":"131","author":"Mauss","year":"1999","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.beem.2010.11.001_bib67","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1097\/00002030-199910220-00013","article-title":"Recombinant human growth hormone improves the fat redistribution syndrome (lipodystrophy) in patients with HIV","volume":"13","author":"Wanke","year":"1999","journal-title":"AIDS"},{"key":"10.1016\/j.beem.2010.11.001_bib68","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1097\/00002030-199912030-00023","article-title":"Recombinant human growth hormone improves truncal adiposity and \u2018buffalo humps\u2019 in HIV-positive patients on HAART","volume":"13","author":"Torres","year":"1999","journal-title":"AIDS"},{"key":"10.1016\/j.beem.2010.11.001_bib69","doi-asserted-by":"crossref","first-page":"3480","DOI":"10.1210\/jcem.86.8.7785","article-title":"The effects of recombinant human growth hormone on body composition and glucose metabolism in HIV-infected patients with fat accumulation","volume":"86","author":"Lo","year":"2001","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2010.11.001_bib70","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1086\/343051","article-title":"Effects of recombinant human growth hormone on fat distribution in patients with human immunodeficiency virus-associated wasting","volume":"35","author":"Tai","year":"2002","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.beem.2010.11.001_bib71","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/00042560-200208010-00002","article-title":"Effect of recombinant human growth hormone in the treatment of visceral fat accumulation in HIV infection","volume":"30","author":"Engelson","year":"2002","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"key":"10.1016\/j.beem.2010.11.001_bib72","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1086\/422725","article-title":"The effects of low-dose growth hormone in HIV-infected men with fat accumulation: a pilot study","volume":"39","author":"Lo","year":"2004","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.beem.2010.11.001_bib73","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/S0140-6736(04)16044-3","article-title":"Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis","volume":"363","author":"Renehan","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.beem.2010.11.001_bib74","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/00126334-200403010-00004","article-title":"Effects of growth hormone on abnormal visceral adipose tissue accumulation and dyslipidemia in HIV-infected patients","volume":"35","author":"Kotler","year":"2004","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"key":"10.1016\/j.beem.2010.11.001_bib75","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/QAI.0b013e31804a7f68","article-title":"Recombinant human growth hormone to treat HIV-associated adipose redistribution syndrome: 12 week induction and 24-week maintenance therapy","volume":"45","author":"Grunfeld","year":"2007","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"key":"10.1016\/j.beem.2010.11.001_bib76","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1001\/jama.300.5.509","article-title":"Low-dose physiological growth hormone in patients with HIV and abdominal fat accumulation: a randomized controlled trial","volume":"300","author":"Lo","year":"2008","journal-title":"Journal of American Medical Association"},{"key":"10.1016\/j.beem.2010.11.001_bib77","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1001\/jama.292.2.210","article-title":"Growth hormone-releasing hormone in HIV-infected men with lipodystrophy: a randomized controlled trial","volume":"292","author":"Koutkia","year":"2004","journal-title":"Journal of American Medical Association"},{"key":"10.1016\/j.beem.2010.11.001_bib78","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1517\/13543780802707658","article-title":"Tesamorelin, a human growth hormone releasing factor analogue","volume":"18","author":"Wang","year":"2009","journal-title":"Expert Opinion on Investigational Drugs"},{"key":"10.1016\/j.beem.2010.11.001_bib79","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1097\/01.aids.0000180099.35146.30","article-title":"A placebo-controlled, dose-ranging study of a growth hormone releasing factor in HIV-infected patients with abdominal fat accumulation","volume":"19","author":"Falutz","year":"2005","journal-title":"AIDS"},{"key":"10.1016\/j.beem.2010.11.001_bib80","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1056\/NEJMoa072375","article-title":"Metabolic effects of a growth hormone-releasing factor in patients with HIV","volume":"357","author":"Falutz","year":"2007","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.beem.2010.11.001_bib81","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/QAI.0b013e3181cbdaff","article-title":"Effects of tesamorelin, a growth hormone-releasing factor, in HIV-infected patients with abdominal fat accumulation: a randomized placebo-controlled trial with a safety extension","volume":"53","author":"Falutz","year":"2010","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"key":"10.1016\/j.beem.2010.11.001_bib82","doi-asserted-by":"crossref","first-page":"4291","DOI":"10.1210\/jc.2010-0490","volume":"95","author":"Falutz","year":"2010","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2010.11.001_bib83","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1097\/QAD.0b013e32830a5058","article-title":"Long-term safety and effects of tesamorelin, a growth hormone-releasing factor analogue, in HIV patients with abdominal fat accumulation","volume":"22","author":"Falutz","year":"2008","journal-title":"AIDS"}],"container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X10001715?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X10001715?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:43:55Z","timestamp":1761497035000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X10001715"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":83,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S1521690X10001715"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2010.11.001","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Growth hormone and HIV infection: Contribution to disease manifestations and clinical implications","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2010.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}